Umakoshi Hironobu, Naruse Mitsuhide, Wada Norio, Ichijo Takamasa, Kamemura Kohei, Matsuda Yuichi, Fujii Yuichi, Kai Tatsuya, Fukuoka Tomikazu, Sakamoto Ryuichi, Ogo Atsushi, Suzuki Tomoko, Nanba Kazutaka, Tsuiki Mika
From the Department of Endocrinology, Metabolism, and Hypertension, Clinical Research Institute, National Hospital Organization Kyoto Medical Center, Kyoto, Japan (H.U., M.N., K.N., M.T.); Department of Diabetes and Endocrinology, Sapporo City General Hospital, Sapporo, Japan (N.W.); Department of Diabetes and Endocrinology, Saiseikai Yokohama City Toubu Hospital, Yokohama City, Japan (T.I.); Department of Cardiology, Akashi Medical Center, Akashi, Japan (K.K.); Department of Cardiology, Sanda City Hospital, Sanda, Japan (Y.M.); Department of Cardiology, Hiroshima General Hospital of West Japan Railway Company, Hiroshima, Japan (Y.F.); Department of Cardiology, Saiseikai Tondabayashi Hospital, Osaka, Japan (T.K.); Department of Internal Medicine, Matsuyama Red Cross Hospital, Matsuyama, Japan (T.F.); Department of Metabolism and Endocrinology, Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan (R.S., A.O.); and Department of Public Health, Kitasato University School of Medicine, Kanagawa, Japan (T.S.).
Hypertension. 2016 May;67(5):1014-9. doi: 10.1161/HYPERTENSIONAHA.115.06607. Epub 2016 Mar 14.
Adrenal venous sampling is considered to be the most reliable diagnostic procedure to lateralize aldosterone excess in primary aldosteronism (PA). However, normative criteria have not been established partially because of a lack of data in non-PA hypertensive patients. The aim of the study was to investigate aldosterone concentration and its gradient in the adrenal vein of non-PA hypertensive patients. We retrospectively studied the results of cosyntropin-stimulated adrenal venous sampling in 40 hypertensive patients who showed positive screening testing but negative results in 2 confirmatory tests/captopril challenge test and saline infusion test. Plasma aldosterone concentration, aldosterone/cortisol ratio, its higher/lower ratio (lateralization index) in the adrenal vein with cosyntropin stimulation were measured. Median plasma aldosterone concentration in the adrenal vein was 25 819 pg/mL (range, 5154-69 920) in the higher side and 12 953 (range, 1866-36 190) pg/mL in the lower side (P<0.001). There was a significant gradient in aldosterone/cortisol ratio between the higher and the lower sides (27.2 [5.4-66.0] versus 17.3 [4.0-59.0] pg/mL per μg/dL;P<0.001) with lateralization index ranging from 1.01 to 3.87. The aldosterone lateralization gradient was between 1 to 2 in 32 patients and 2 to 4 in 8 patients. None of the patients showed lateralization index ≥4. The present study demonstrated that plasma aldosterone concentration in the adrenal veins showed significant variation and lateralization gradient even in non-PA hypertensive patients. Adrenal venous sampling aldosterone lateralization gradients between 2 and 4 should be interpreted with caution in patients with PA because these gradients can be found even in patients with negative confirmatory testing for PA.
肾上腺静脉采血被认为是在原发性醛固酮增多症(PA)中定位醛固酮分泌过多的最可靠诊断方法。然而,由于非PA高血压患者的数据缺乏,尚未建立规范标准。本研究的目的是调查非PA高血压患者肾上腺静脉中的醛固酮浓度及其梯度。我们回顾性研究了40例高血压患者促肾上腺皮质激素刺激下肾上腺静脉采血的结果,这些患者筛查试验呈阳性,但在两项确诊试验/卡托普利激发试验和盐水输注试验中结果为阴性。测量了促肾上腺皮质激素刺激下肾上腺静脉中的血浆醛固酮浓度、醛固酮/皮质醇比值、其较高/较低比值(定位指数)。肾上腺静脉中血浆醛固酮浓度较高一侧的中位数为25819 pg/mL(范围5154 - 69920),较低一侧为12953 pg/mL(范围1866 - 36190)(P<0.001)。较高侧与较低侧的醛固酮/皮质醇比值存在显著梯度(分别为27.2 [5.4 - 66.0]与17.3 [4.0 - 59.0] pg/mL per μg/dL;P<0.001),定位指数范围为1.01至3.87。醛固酮定位梯度在32例患者中为1至2,8例患者中为2至4。没有患者的定位指数≥4。本研究表明,即使在非PA高血压患者中,肾上腺静脉中的血浆醛固酮浓度也显示出显著变化和定位梯度。对于PA患者,肾上腺静脉采血醛固酮定位梯度在2至4之间时应谨慎解释,因为即使在PA确诊试验阴性的患者中也可发现这些梯度。